Geode Capital Management
CYCN icon

Geode Capital Management’s Cyclerion Therapeutics CYCN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$95.3K Buy
32,735
+1,132
+4% +$3.3K ﹤0.01% 4071
2025
Q1
$78.1K Sell
31,603
-217
-0.7% -$536 ﹤0.01% 4099
2024
Q4
$102K Sell
31,820
-2,088
-6% -$6.73K ﹤0.01% 4091
2024
Q3
$87.5K Sell
33,908
-70
-0.2% -$181 ﹤0.01% 4144
2024
Q2
$77.5K Buy
33,978
+1,896
+6% +$4.32K ﹤0.01% 4196
2024
Q1
$103K Buy
32,082
+823
+3% +$2.63K ﹤0.01% 4153
2023
Q4
$105K Buy
31,259
+510
+2% +$1.71K ﹤0.01% 4177
2023
Q3
$105K Buy
30,749
+1,027
+3% +$3.49K ﹤0.01% 4235
2023
Q2
$122K Sell
29,722
-562,515
-95% -$2.31M ﹤0.01% 4254
2023
Q1
$257K Buy
592,237
+5,500
+0.9% +$2.39K ﹤0.01% 3922
2022
Q4
$385K Buy
586,737
+2,918
+0.5% +$1.92K ﹤0.01% 3795
2022
Q3
$502K Buy
583,819
+10,125
+2% +$8.71K ﹤0.01% 3725
2022
Q2
$314K Sell
573,694
-9,689
-2% -$5.3K ﹤0.01% 4007
2022
Q1
$647K Buy
583,383
+17,548
+3% +$19.5K ﹤0.01% 3816
2021
Q4
$973K Buy
565,835
+75,175
+15% +$129K ﹤0.01% 3738
2021
Q3
$1.51M Buy
490,660
+105,840
+28% +$325K ﹤0.01% 3485
2021
Q2
$1.5M Sell
384,820
-102,139
-21% -$398K ﹤0.01% 3397
2021
Q1
$1.36M Buy
486,959
+53,097
+12% +$148K ﹤0.01% 3430
2020
Q4
$1.33M Buy
433,862
+80,891
+23% +$247K ﹤0.01% 3273
2020
Q3
$2.15M Buy
352,971
+36,818
+12% +$224K ﹤0.01% 2843
2020
Q2
$1.87M Sell
316,153
-6,849
-2% -$40.5K ﹤0.01% 2882
2020
Q1
$855K Buy
323,002
+22,629
+8% +$59.9K ﹤0.01% 3077
2019
Q4
$817K Buy
300,373
+54,500
+22% +$148K ﹤0.01% 3346
2019
Q3
$2.98M Buy
245,873
+4,427
+2% +$53.6K ﹤0.01% 2695
2019
Q2
$2.76M Buy
+241,446
New +$2.76M ﹤0.01% 2744